Articles in E-pub version are posted online ahead of regular printed publication.

Correspondences Advancing Policy and Practice in Alcohol-Associated Liver Disease and Alcohol-Attributable Cancer: Correspondence to the editorial on “Rising Burden of Alcohol-Associated Liver Disease and Cancers: Insights into Sex Disparities and Policy Implications”

Pojsakorn Danpanichkul, Donghee Kim, Karn Wijarnpreecha, Amit G. Singal, Ju Dong Yang

DOI: 10.3350/cmh.2025.0527  [Epub ahead of print]

Correspondence: Response to Editorial on “Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma”

Tiantian Wang, Wenjie Huang, Limin Xia

DOI: 10.3350/cmh.2025.0523  [Epub ahead of print]

Editorials Rising Burden of Alcohol-Associated Liver Disease and Cancers: Insights into Sex Disparities and Policy Implications

Sung-Eun Kim

DOI: 10.3350/cmh.2025.0516  [Epub ahead of print]

Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma

Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

DOI: 10.3350/cmh.2025.0515  [Epub ahead of print]

Correspondences Correspondence: Response to Editorial on “Unveiling TRIB3: A New Mediator in MET-Driven Hepatocellular Carcinoma Progression”

Tiantian Wang, Wenjie Huang, Limin Xia

DOI: 10.3350/cmh.2025.0507  [Epub ahead of print]

Replys to Correspondence Advancing Metabolic Risk Profiling in Chronic Hepatitis B

Shang-Chin Huang, Jia-Horng Kao

DOI: 10.3350/cmh.2025.0500  [Epub ahead of print]

Reply to correspondence on “A Novel Link Between Tumor Cell Metabolism and Patient Prognosis: Editorial on ‘Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway’”

Eun Ji Jang, Pil Soo Sung

DOI: 10.3350/cmh.2025.0498  [Epub ahead of print]

Correspondences Correspondence to editorial “Metabolic health in antiviral era of chronic hepatitis B”

Rui Huang, Mindie H. Nguyen

DOI: 10.3350/cmh.2025.0479  [Epub ahead of print]

Correspondence to editorial “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”

Rui Huang, Mindie H. Nguyen

DOI: 10.3350/cmh.2025.0478  [Epub ahead of print]

Correspondence to letter to the editor on “Risk Stratification of Metabolic Dysfunction-Associated Steatotic Liver Disease: The KASL Pathway

Hye Won Lee, Seung Up Kim

DOI: 10.3350/cmh.2025.0477  [Epub ahead of print]

Research Letters Non-infectivity of Hepatitis B Virus Under Nucleoside Analog Therapy Revealed Through Auxiliary Partial Orthotopic Liver Transplantation (APOLT)

Xiaojie Chen, Guiwen Guan, Lin Wei, Jidong Jia, Xiangmei Chen, Fengmin Lu, Zhijun Zhu

DOI: 10.3350/cmh.2025.0393  [Epub ahead of print]

Contemporary Burden of Mortality from Chronic Liver Disease by Sex and Race/Ethnicity in the United States

Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed

DOI: 10.3350/cmh.2025.0384  [Epub ahead of print]

Letters to the Editor Molecular Stratification of Hepatocellular Carcinoma by Metabolic-Signaling Pathways Guides Precision Immunotherapy and TACE Therapy

Binghua Li, Yanchao Xu, Yican Zhu, Yukun Zhang, Zijie Wu, Tianci Luo, Laizhu Zhang, Weiwei Hu, Decai Yu

DOI: 10.3350/cmh.2025.0344  [Epub ahead of print]

Editorials Unveiling TRIB3: A New Mediator in MET-Driven Hepatocellular Carcinoma Progression

Many Sze Man CHAN, Terence Kin Wah LEE

DOI: 10.3350/cmh.2025.0452  [Epub ahead of print]

Correspondences Correspondence to editorial on “Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway.”

Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo

DOI: 10.3350/cmh.2025.0435  [Epub ahead of print]

Editorials Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B

Heejoon Jang, Won Kim

DOI: 10.3350/cmh.2025.0430  [Epub ahead of print]

RISK STRATIFICATION OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: THE KASL PATHWAY

May Xuan GOH, Xin En GOH, Jarell Jie-Rae TAN, Vincent L CHEN, Yu Jun WONG

DOI: 10.3350/cmh.2025.0420  [Epub ahead of print]

Replys to Correspondence GULP1: New Hope for Hepatocellular Carcinoma: Reply to Correspondence on “GULP1 as a Novel Biomarker in HCC”

Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen

DOI: 10.3350/cmh.2025.0415  [Epub ahead of print]

Correspondences Correspondence to editorial “Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma”

Yifei Qin, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu

DOI: 10.3350/cmh.2025.0402  [Epub ahead of print]

Letters to the Editor Letter “Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target”

Yuqian Liu, Ruiyun Guo, Jun Ma

DOI: 10.3350/cmh.2025.0377  [Epub ahead of print]

Original Articles GLP-1 RA and Reduced Liver and Non-Liver Complications in Adults with T2D and MASLD: A Target Trial Emulation Study

Xianhua Mao, Xinrong Zhang, Rongtao Lai, Ka-Shing Cheung, Man-Fung Yuen, Ramsey Cheung, Wai-Kay Seto, Mindie H Nguyen

DOI: 10.3350/cmh.2024.1096  [Epub ahead of print]

HTD1801 Demonstrates Promising Potential for Histologic Improvements in MASH in Both a Preclinical and Phase 2 Study

Vincent Wai-Sun Wong, Guy W. Neff, Adrian M. Di Bisceglie, Ru Bai, Junwei Cheng, Meng Yu, Alexander Liberman, Liping Liu, Nadege Gunn

DOI: 10.3350/cmh.2025.0145  [Epub ahead of print]

Editorials A Novel Link Between Tumor Cell Metabolism and Patient Prognosis: Editorial on “Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway”

Eun Ji Jang, Pil Soo Sung

DOI: 10.3350/cmh.2025.0395  [Epub ahead of print]

Replys to Correspondence Reply to authors’ reply: “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”

Mathias Jachs, Mattias Mandorfer

DOI: 10.3350/cmh.2025.0391  [Epub ahead of print]

Reviews Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunction-associated steatotic liver disease

Eiji Kakazu, Masaaki Mino, Tatsuya Kanto

DOI: 10.3350/cmh.2025.0048  [Epub ahead of print]

Correspondences Correspondence to Editorial on “Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial”

Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Jin Mo Yang

DOI: 10.3350/cmh.2025.0379  [Epub ahead of print]

Editorials Metabolic Health in Antiviral Era of Chronic Hepatitis B

Shang-Chin Huang, Jia-Horng Kao

DOI: 10.3350/cmh.2025.0369  [Epub ahead of print]

Viral manipulation of host cell glutamine metabolism and glutamine rewiring in hepatic diseases: Editorial on “GDH1-dependent α-ketoglutarate promotes HBV transcription by modulating histone methylations on the cccDNA minichromosome”

Mehrangiz Dezhbord, Kyun-Hwan Kim

DOI: 10.3350/cmh.2025.0366  [Epub ahead of print]

Original Articles Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States

Pojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, Primrose Tothanarungroj, Luis Antonio Díaz, Juan Pablo Arab, Pimtawan Jatupornpakdee, Mark D. Muthiah, Kwanjit Duangsonk, Won-Mook Choi, Daniel Q. Huang, Donghee Kim, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul, Amit G. Singal, Ju Dong Yang

DOI: 10.3350/cmh.2025.0169  [Epub ahead of print]

MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation

Tiantian Wang, Dean Rao, Chenan Fu, Zhoubin Sun, Yiming Luo, Junli Lu, Jie Jin, Han Li, Feimu Fan, Huifang Liang, Wenjie Huang, Limin Xia

DOI: 10.3350/cmh.2024.1163  [Epub ahead of print]

Correspondences Revisiting unmet needs in clinical research on direct-acting antiviral therapy for HCC patients

Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu

DOI: 10.3350/cmh.2025.0362  [Epub ahead of print]

Correspondence: Response to Editorial on “GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC”

Soon Sun Kim, Hyung Seok Kim, Jae Youn Cheong, Jung Woo Eun

DOI: 10.3350/cmh.2025.0350  [Epub ahead of print]

Original Articles Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease

Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim

DOI: 10.3350/cmh.2024.1183  [Epub ahead of print]

Research Letters Lipidomic analysis of alcohol use disorder patients revealed the biomarkers for alcohol-related liver disease susceptibility

Dongyao Wang, Hongwei Zhang, Yuxiao Tang

DOI: 10.3350/cmh.2025.0227  [Epub ahead of print]

Reviews Emerging Therapies and Real-World Application of Metabolic Dysfunction-Associated Steatotic Liver Disease Treatment

Hee Yeon Kim, Mary E. Rinella

DOI: 10.3350/cmh.2025.0083  [Epub ahead of print]

Editorials Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma

Valerie Chew

DOI: 10.3350/cmh.2025.0334  [Epub ahead of print]

Correspondences Correspondence to editorial 3 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”

Haiyu Wang, Jinjun Chen

DOI: 10.3350/cmh.2025.0328  [Epub ahead of print]

Correspondence to editorial 2 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”

Haiyu Wang, Jinjun Chen

DOI: 10.3350/cmh.2025.0327  [Epub ahead of print]

Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”

Haiyu Wang, Jinjun Chen

DOI: 10.3350/cmh.2025.0326  [Epub ahead of print]

Reviews Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury – chronic kidney disease spectrum

Vishnu Girish, Rakhi Maiwall

DOI: 10.3350/cmh.2024.1060  [Epub ahead of print]

Editorials GULP1, A Multifaceted Diagnostic Biomarker and Potential Therapeutic Target in Hepatocellular Carcinoma: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen

DOI: 10.3350/cmh.2025.0315  [Epub ahead of print]

Besifovir: a viable option for long-term disease control in chronic hepatitis B

Wai-Kay Seto

DOI: 10.3350/cmh.2025.0305  [Epub ahead of print]

Refining Portal Hypertension Assessment: The Clinical Significance of Spleen Stiffness Measurement in the Baveno VII Era

Do Seon Song

DOI: 10.3350/cmh.2025.0296  [Epub ahead of print]

Letters to the Editor Letter “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”

Qiong Wang, Zhongqing Qian, Xiaodi Yang, Deyan Chen, Xiaojing Wang, Fuliang Chen

DOI: 10.3350/cmh.2025.0291  [Epub ahead of print]

Correspondences Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"

Hyung Seok Kim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

DOI: 10.3350/cmh.2025.0287  [Epub ahead of print]

Editorials Unveiling GULP1 as a Hepatocyte-Specific Role for Recurrence: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Pengde Lu, Ning Wang

DOI: 10.3350/cmh.2025.0282  [Epub ahead of print]

A non-invasive risk stratification tool for hepatitis B-related liver cirrhosis: the Baveno VI-SSM combined model.

Ruiling He, Bingtian Dong, Xiaolong Qi

DOI: 10.3350/cmh.2025.0281  [Epub ahead of print]

Predicting decompensation risk in compensated HBV cirrhosis: Eternal sunshine for a spotless mind?

Mathias Jachs, Mattias Mandorfer

DOI: 10.3350/cmh.2025.0280  [Epub ahead of print]

The Evolution of Non-Invasive Strategies in Cirrhosis Management—From Screening to Precision Monitoring：Editorial on ‘FIB-4plus Score: A novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): An international multicenter study’

Haiyu Wang, Jinjun Chen

DOI: 10.3350/cmh.2025.0274  [Epub ahead of print]

Letters to the Editor Critical Considerations in Evaluating the Therapeutic Potential of HK-660S for Primary Sclerosing Cholangitis

He Yizi, He Haifeng, Liang Qi, Xie Yongzhi

DOI: 10.3350/cmh.2025.0239  [Epub ahead of print]

Original Articles Impact of components of metabolic syndrome on long-term outcomes of CHB with nucleos(t)ide analogue treatment

Rui Huang, Dae Won Jun, Hidenori Toyoda, Yao-Chun Hsu, Huy Trinh, Akito Nozaki, Toru Ishikawa, Tsunamasa Watanabe, Haruki Uojima, Daniel Q. Huang, Takashi Honda, Yasuhito Tanaka, Philip Vutien, Sebastián Marciano, Hiroshi Abe, Masaru Enomoto, Masanori Atsukawa, Hirokazu Takahashi, Kunihiko Tsuji, Koichi Takaguchi, Pei-Chien Tsai, Chia-Yen Dai, Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Eileen Yoon, Sung Eun Kim, Sang Bong Ahn, Gi-Ae Kim, Jang Han Jung, Soung Won Jeong, Hyunwoo Oh, Cheng-Hao Tseng, Masatoshi Ishigami, Angela Chau, Mayumi Maeda, Satoshi Yasuda, Makoto Chuma, Takanori Ito, Keigo Kawashima, Joanne Kimiko Liu, Adrian Gadano, Ritsuzo Kozuka, Norio Itokawa, Kaori Inoue, Tomonori Senoh, Jie Li, Wan-Long Chuang, Ramsey Cheung, Chao Wu, Ming-Lung Yu, Mindie H. Nguyen

DOI: 10.3350/cmh.2024.1070  [Epub ahead of print]

Replys to Correspondence SHOULD DIRECT-ACTING ANTIVIRAL BE CONSIDERED FOR ALL PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA?

Yan Ling ONG, Apichat KAEWDECH, Yu Jun WONG

DOI: 10.3350/cmh.2025.0257  [Epub ahead of print]

Editorials Modulation of PRL-1 in Placental MSCs: A Novel Therapeutic Strategy for Hepatic Fibrosis: Editorial on “Modulation of PRL-1 within placental MSCs instigates the transition between EMT and MET subsequent to hepatic fibrosis”

Lihai Jiang, Wenjie Zheng

DOI: 10.3350/cmh.2025.0264  [Epub ahead of print]

Regulation of Hepatitis B Virus cccDNA by Metabolic Pathways

Hyeong-Jin Cho, Sung-Gyoo Park

DOI: 10.3350/cmh.2025.0255  [Epub ahead of print]

Original Articles Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway

Tomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, Kazuko Sakai, Naoto Fujiwara, Masakatsu Tsurusaki, Kohei Hanaoka, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Kazuomi Ueshima, Yasunori Minami, Atsushi Takebe, Takaaki Murase, Keiko Kamei, Takuya Nakai, Ippei Matsumoto, Kazuto Nishio, Masatoshi Kudo

DOI: 10.3350/cmh.2024.1088  [Epub ahead of print]

Letters to the Editor Letter “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”

Juan Yang, Xinyi Li, Sheng Zheng

DOI: 10.3350/cmh.2025.0216  [Epub ahead of print]

Letter to the Editor on “Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023”

Sisi Yang, Zhenxuan Ma

DOI: 10.3350/cmh.2025.0153  [Epub ahead of print]

Correspondences Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage

Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu

DOI: 10.3350/cmh.2025.0235  [Epub ahead of print]

Research Letters Mendelian randomization does not support the effects of G-CSF on decompensated liver disease

Li Liling, Wang Hui, Wang Hong, Huang Jinchang

DOI: 10.3350/cmh.2025.0172  [Epub ahead of print]

Special Review Liver Disease Trends in the Asia-Pacific Region for the Next 50 Years

Shuichiro Shiina, Javkhlan Maikhuu, Qing Deng, Terguunbileg Batsaikhan, Lariza Marie Canseco, Maki Tobari, Hitoshi Maruyama, Hiroaki Nagamatsu, Diana Alcantara-Payawal, Rino Gani, Yi-Hsiang Huang, Tawesak Tanwandee, Giovanni Galati, Yoon Jun Kim

DOI: 10.3350/cmh.2025.0043  [Epub ahead of print]

Original Articles CD36 Promotes Iron Accumulation and Dysfunction in CD8⁺ T Cells via the p38-CEBPB-TfR1 Axis in Early-stage Hepatocellular Carcinoma

Yifei Qin, Fei Huo, Zhuan Feng, Jialu Hou, Yaxin Ding, Quancheng Wang, Yu Gui, Ziwei Yang, Jiali Yang, Gang Zhou, Ling Li, Jianli Jiang, Lingmin Kong, Shijie Wang, Gang Nan, Dingqiao Xu, Xiaohang Xie, Lijuan Wang, Qian He, Ruibin Yang, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu

DOI: 10.3350/cmh.2024.0948  [Epub ahead of print]

Letters to the Editor Re: "Bariatric Surgery Reduces Long-Term Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Cirrhosis"

Weixiong Zhu, Xuefan Zeng, Zengxi Yang, Yusheng Cheng, Wence Zhou

DOI: 10.3350/cmh.2025.0189  [Epub ahead of print]

Correspondences HCC predictors in routine practice for patients with chronic liver diseases

Tung-Hung Su, Jia-Horng Kao

DOI: 10.3350/cmh.2025.0187  [Epub ahead of print]

Editorials Direct-acting antiviral attained sustained virological response improve overall survival in patients with HCV-related hepatocellular carcinoma

Yan Ling Ong, Apichat Kaewdech, Daniel Q Huang, Yu Jun Wong

DOI: 10.3350/cmh.2025.0174  [Epub ahead of print]

Letters to the Editor Classification of microvascular invasion of hepatocellular carcinoma: different standards, common goals

Wei Chen, Yihui Rong, Tianshi Ma, Weiwei Shi, Wei Chen, Hang Jiang

DOI: 10.3350/cmh.2025.0167  [Epub ahead of print]

Editorials Can SAFE score be utilized as a universal hepatocellular carcinoma prediction score? Editorial on “High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease”

Michael Kwan-Lung Ko, Loey Lung-Yi Mak

DOI: 10.3350/cmh.2025.0118  [Epub ahead of print]

Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease

Ho Soo Chun, Minjong Lee

DOI: 10.3350/cmh.2025.0116  [Epub ahead of print]

Original Articles Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target

Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, Shu-Ya Cao, Chen-Yu Jiao, Ming Lu, Biao Zhang, Yue Yang, Qing Xu, Xiao-Feng Wu, Ke Wang, Yong-Xiang Xia, Xiang-Cheng Li, Xue-Hao Wang

DOI: 10.3350/cmh.2024.0895  [Epub ahead of print]

Letters to the Editor Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”

Chi-Kuei Hsu, Po-Yu Huang, Chih-Cheng Lai

DOI: 10.3350/cmh.2025.0073  [Epub ahead of print]

Snapshot Interventions Targeting the Gut-Liver Axis: A Potential Treatment Strategy for MASLD

Pingping Jin, Xinyi Lu, Daozhen Chen, Yu Chen

DOI: 10.3350/cmh.2024.1090  [Epub ahead of print]

Original Articles GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma

Hyung Seok Kim, Jung Hwan Yoon, Ji Yi Choi, Moon Gyeong Yoon, Geum Ok Baek, Minji Kang, Se Ha Jang, Won Park, Yunjin Go, Jestlin Tianthing Ng, Suk Woo Nam, Jee-Yeong Jeong, Ji Eun Han, Hyo Jung Cho, Su Bin Lim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

DOI: 10.3350/cmh.2024.1038  [Epub ahead of print]

Reviews Deciphering adenosine signaling in hepatocellular carcinoma: pathways, prognostic models, and therapeutic implications

Huihai Yang, Martina Mang Leng Lei, Longfei Xie, Yinuo Shou, Terence Kin Wah Lee

DOI: 10.3350/cmh.2024.1068  [Epub ahead of print]

Original Articles Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study

Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing-Tao Kuo, Kuo-Chih Tseng, Lein-Ray Mo, Ching-Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Teng-Yu Lee, Ming- Lung Yu

DOI: 10.3350/cmh.2024.1015  [Epub ahead of print]

FIB-4plus Score: A novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): An international multicenter study

Bingtian Dong, Ruiling He, Shenghong Ju, Yuping Chen, Ivica Grgurevic, Jianzhong Ma, Ying Guo, Huizhen Fan, Qiang Yan, Chuan Liu, Huixiong Xu, Anita Madir, Kristian Podrug, Jia Wang, Linxue Qian, Zhengzi Geng, Shanghao Liu, Tao Ren, Guo Zhang, Kun Wang, Meiqin Su, Fei Chen, Sumei Ma, Liting Zhang, Zhaowei Tong, Yonghe Zhou, Xin Li, Fanbin He, Hui Huan, Wenjuan Wang, Yunxiao Liang, Juan Tang, Fang Ai, Tingyu Wang, Liyun Zheng, Zhongwei Zhao, Jiansong Ji, Wei Liu, Jiaojiao Xu, Bo Liu, Xuemei Wang, Yao Zhang, Qiong Yan, Hui Liu, Xiaomei Chen, Shuhua Zhang, Yihua Wang, Yang Liu, Li Yin, Yanni Liu, Yanqing Huang, Li Bian, Ping An, Xin Zhang, Shaoting Zhang, Jinhua Shao, Xiangman Zhang, Wei Rao, Chaoxue Zhang, Christoph Frank Dietrich, Won Kim, Xiaolong Qi

DOI: 10.3350/cmh.2024.0898  [Epub ahead of print]

GDH1-dependent α-ketoglutarate promotes HBV transcription by modulating histone methylations on the cccDNA minichromosome

Sheng-Tao Cheng, Wei-Xian Chen, Hai-Jun Deng, Xin He, Hui Zhang, Ming Tan, Hai-Bo Yu, Zhen-Zhen Zhang, Ji-Hua Ren, Min-Li Yang, Da-Peng Zhang, Zhi-Hong Li, Juan Chen

DOI: 10.3350/cmh.2024.0694  [Epub ahead of print]

Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis

Haiyu Wang, Weihao Liang, Ling Zhou, Jiankang Song, Biao Wen, Qiaoping Wu, Yuanjian Zhang, Xiaofeng Zhang, Haoran Ke, Yujun Tang, Fuyuan Zhou, Youfu Zhu, Weiqun Wen, Zhihua Liu, Yali Ji, Qintao Lai, Qinjun He, Wenfan Luo, Tingting Qi, Miaoxia Liu, Xiaoqin Lan, Yongpeng Chen, Ranran Xi, Junting Wan, Lin Dai, Yuan Li, Jinjun Chen

DOI: 10.3350/cmh.2024.0609  [Epub ahead of print]

Reviews Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications

Xindi Ke, Shangze Jiang, Qiaoxin Wei, Minghao Sun, Hang Sun, Mingchang Pang, Mei Liu, Lejia Sun, Huayu Yang, Yilei Mao

DOI: 10.3350/cmh.2024.1039  [Epub ahead of print]

Original Articles Modulation of PRL-1 within placental MSCs instigates the transition between EMT and MET subsequent to hepatic fibrosis

Jae Yeon Kim, Hyeri Park, Soo Young Park, Se Ho Kim, Ja Yun Lim, Ki Seog Lee, Si Hyun Bae, Gi Jin Kim

DOI: 10.3350/cmh.2024.0741  [Epub ahead of print]

Letters to the Editor What is new in the 2024 Chinese guidelines for fatty liver disease?

Rui-Xu Yang, Vincent Wai-Sun Wong, Jian-Gao Fan

DOI: 10.3350/cmh.2024.1165  [Epub ahead of print]

Original Articles Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial

Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Woong Lee, Jung Hyun Kwon, Moon Young Kim, Do Seon Song, Jung Gil Park, Yoon Seok Lee, Eileen L. Yoon, Han Ah Lee, Seong Hee Kang, Jin Mo Yang

DOI: 10.3350/cmh.2024.0819  [Epub ahead of print]

High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease

Tung-Hung Su, Sheng-Shun Yang, Mei-Hsuan Lee, Wei-Yu Kao, Shang-Chin Huang, Fen-Fang Chen, Francis SK Poon, Lung-Wen Tsai, Yi-Ting Chen, Che Lin, Weichung Wang, W Ray Kim, Jia-Horng Kao

DOI: 10.3350/cmh.2024.0822  [Epub ahead of print]

Letters to the Editor Current Burden of MASLD, MetALD, and Hepatic Fibrosis among US Adults with Prediabetes and Diabetes, 2017-2023

Donghee Kim, Rohit Loomba, Aijaz Ahmed

DOI: 10.3350/cmh.2024.1150  [Epub ahead of print]

Original Articles Plasma lipidomics and fungal peptide-based community analysis identifies distinct signatures for early mortality in acute liver failure

Neha Sharma, Sushmita Pandey, Gaurav Tripathi, Manisha Yadav, Nupur Sharma, Babu Mathew, Abhishak Gupta, Vasundhra Bindal, Sadam H. Bhat, Yash magar, Rimsha Saif, Sanju Yadav, Amritpal Kaur, Rakhi Maiwall, Shvetank Sharma, Shiv Kumar Sarin, Jaswinder Singh Maras

DOI: 10.3350/cmh.2024.0554  [Epub ahead of print]